The mission of Lee's Pharm is to become a successful biopharmaceutical group in Asia providing innovative products to fight diseases and improve health and quality of life.

Listed on the GEM of the Stock Exchange of Hong Kong (“HKEx”) Limited since July 2002 and successfully transferred of listing to the Main Board of the HKEx in May 2010, Lee's Pharmaceutical Holdings Limited (“Lee's Pharm” or “the Group”) is an integrated research-driven and market oriented biopharmaceutical company publicly listed in Hong Kong with over 25 years’ experience in the pharmaceutical industry in China.